Kazia Therapeutics Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Kazia Therapeutics Limited generated cash of -$9,581,000, which is more than the previous year. Cash used in financing activities reached the amount of $5,985,000 last year. Net change in cash is therefore -$3,584,000.
Cash Flow
| 2015 | -5.75M | -89.67K | 47.41M |
|---|---|---|---|
| 2016 | -11.98M | -522K | 782K |
| 2017 | -11.43M | -7.11M | -17.66K |
| 2018 | -8.66M | 150K | 0 |
| 2019 | -6.71M | 2.35M | 3.81M |
| 2020 | -8.81M | 0 | 12.14M |
| 2021 | -9.11M | 0 | 28.10M |
| 2022 | -22.76M | -2.36M | 3.72M |
| 2023 | -15.15M | 0 | 12.97M |
| 2024 | -9.58M | 0 | 5.98M |
KZIA Cash Flow Statement (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 5.24M | 7.36M | 27.58M | 8.76M | 5.43M | 5.95M | 14.45M | 33.45M | 44.37M | 2.50M |
Operating activities | ||||||||||
Net income | -26.77M | -20.46M | -24.64M | -8.42M | -12.46M | -10.27M | -6.03M | -10.67M | -12.15M | -7.30M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 1.86M | 1.86M | 1.95M | 1.26M | 1.08M | 1.08M | 1.54M | 1.41M | 643K | 574.96K |
Stock-based compensation expense | 533K | 1.15M | 1.67M | 637K | 262K | 246K | 0 | 517K | 372K | 0 |
| Deferred income tax benefit | 533K | 1.15M | 1.67M | 637K | 262K | 246K | 0 | 517K | 372K | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 5K | 3.44M | -6K | -5.02M | 358K | 825K | 1.72M | -4.02M | 15K | -84.63K |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by operating activities | -9.58M | -15.15M | -22.76M | -9.11M | -8.81M | -6.71M | -8.66M | -11.43M | -11.98M | -5.75M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -11.64K | -525K | -97.47K |
Acquisitions Net | 0 | 0 | -2.36M | 0 | 0 | 0 | 0 | -7.09M | 0 | 0 |
Cash generated by investing activities | 0 | 0 | -2.36M | 0 | 0 | 2.35M | 150K | -7.11M | -522K | -89.67K |
Financing activities | ||||||||||
Common Stock Issued | 5.58M | 12.97M | 3.72M | 28.10M | 12.97M | 3.81M | 0 | 0 | 853K | 50.35M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 405K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 5.98M | 12.97M | 3.72M | 28.10M | 12.14M | 3.81M | 0 | -17.66K | 782K | 47.41M |
Net Change In Cash | -3.58M | -2.11M | -20.22M | 18.82M | 3.33M | -522K | -8.49M | -18.99M | -10.91M | 41.86M |
Cash at end of period | 1.65M | 5.24M | 7.36M | 27.58M | 8.76M | 5.43M | 5.95M | 14.45M | 33.45M | 44.37M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |